% alzhub.org library filter % Source: https://alzhub.org/research?author=Kasuga+K % 4 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{mori2021-33967943, author = {Mori, Y. and Tsuji, M. and Oguchi, T. and Kasuga, K. and Kimura, A. and Futamura, A. and Sugimoto, A. and Kasai, H. and others}, title = {{Serum BDNF as a Potential Biomarker of Alzheimer's Disease: Verification Through Assessment of Serum, Cerebrospinal Fluid, and Medial Temporal Lobe Atrophy}}, journal = {Frontiers in neurology}, year = {2021}, doi = {10.3389/fneur.2021.653267}, pmid = {33967943}, url = {https://doi.org/10.3389/fneur.2021.653267} } @article{tokutake2012-22910909, author = {Tokutake, T. and Kasuga, K. and Yajima, R. and Sekine, Y. and Tezuka, T. and Nishizawa, M. and Ikeuchi, T.}, title = {{Hyperphosphorylation of Tau induced by naturally secreted amyloid-β at nanomolar concentrations is modulated by insulin-dependent Akt-GSK3β signaling pathway}}, journal = {The Journal of biological chemistry}, year = {2012}, doi = {10.1074/jbc.m112.348300}, pmid = {22910909}, url = {https://doi.org/10.1074/jbc.m112.348300} } @article{kaneko2007-18045903, author = {Kaneko, H. and Kakita, A. and Kasuga, K. and Nozaki, H. and Ishikawa, A. and Miyashita, A. and Kuwano, R. and Ito, G. and others}, title = {{Enhanced accumulation of phosphorylated alpha-synuclein and elevated beta-amyloid 42/40 ratio caused by expression of the presenilin-1 deltaT440 mutant associated with familial Lewy body disease and variant Alzheimer's disease}}, journal = {The Journal of neuroscience : the official journal of the Society for Neuroscience}, year = {2007}, doi = {10.1523/jneurosci.4244-07.2007}, pmid = {18045903}, url = {https://doi.org/10.1523/jneurosci.4244-07.2007} } @article{sato2026-a8cec4bf, author = {Sato, K. and Niimi, Y. and Nakashima, S. and Igarashi, A. and Iwata, A. and Kasuga, K. and Nemoto, K. and Higashi, S. and others}, title = {{Protocol for the 2026 Nationwide Survey of Dementia Specialists on the Real-World Implementation of Anti-Amyloid Antibody Therapies in Japan: Clinical Practice, Blood Biomarkers, and Preference Experiments}}, journal = {medRxiv}, year = {2026}, doi = {10.64898/2026.06.30.26356494}, url = {https://doi.org/10.64898/2026.06.30.26356494} }